Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine
dc.contributor.author | Hager, Karen J | |
dc.contributor.author | Pérez Marc, Gonzalo | |
dc.contributor.author | Gobeil, Philipe | |
dc.contributor.author | Diaz, Ricardo S | |
dc.contributor.author | Heizer, Gretchen | |
dc.contributor.author | Llapur, Conrado | |
dc.contributor.author | Makarkov, Alexander I | |
dc.contributor.author | Vasconcellos, Eduardo | |
dc.contributor.author | Pillet, Stéphane | |
dc.contributor.author | Riera, Fernando | |
dc.contributor.author | Saxena, Pooja | |
dc.contributor.author | Geller Wolff, Priscila | |
dc.contributor.author | Bhutada, Kapil | |
dc.contributor.author | Wallace, Garry | |
dc.contributor.author | Aazami, Hessam | |
dc.contributor.author | Jones, Christine E | |
dc.contributor.author | Polack, Fernando P | |
dc.contributor.author | Ferrara, Luciana | |
dc.contributor.author | Atkins, Judith | |
dc.contributor.author | Boulay, Iohann | |
dc.contributor.author | Dhaliwall, Jiwanjeet | |
dc.contributor.author | Charland, Nathalie | |
dc.contributor.author | Couture, Manon M J | |
dc.contributor.author | Jiang-Wright, Julia | |
dc.contributor.author | Landry, Nathalie | |
dc.contributor.author | Lapointe, Sophie | |
dc.contributor.author | Lorin, Aurélien | |
dc.contributor.author | Mahmood, Asif | |
dc.contributor.author | Moulton, Lawrence H | |
dc.contributor.author | Pahmer, Emily | |
dc.contributor.author | Parent, Julie | |
dc.contributor.author | Séguin, Annie | |
dc.contributor.author | Tran, Luan | |
dc.contributor.author | Breuer, Thomas | |
dc.contributor.author | Ceregido, Maria-Angeles | |
dc.contributor.author | Koutsoukos, Marguerite | |
dc.contributor.author | Roman, François | |
dc.contributor.author | Namba, Junya | |
dc.contributor.author | D'Aoust, Marc-André | |
dc.contributor.author | Trepanier, Sonia | |
dc.contributor.author | Kimura, Yosuke | |
dc.contributor.author | Ward, Brian J | |
dc.contributor.author | CoVLP Study Team | |
dc.date.accessioned | 2023-03-09T00:05:39Z | |
dc.date.available | 2023-03-09T00:05:39Z | |
dc.date.issued | 2022-06-02 | |
dc.identifier | 215488332 | |
dc.identifier | 2bf7cf74-309d-41cf-a9f1-4b80ef7f7097 | |
dc.identifier | 35507508 | |
dc.identifier | 85130324475 | |
dc.identifier.citation | Hager , K J , Pérez Marc , G , Gobeil , P , Diaz , R S , Heizer , G , Llapur , C , Makarkov , A I , Vasconcellos , E , Pillet , S , Riera , F , Saxena , P , Geller Wolff , P , Bhutada , K , Wallace , G , Aazami , H , Jones , C E , Polack , F P , Ferrara , L , Atkins , J , Boulay , I , Dhaliwall , J , Charland , N , Couture , M M J , Jiang-Wright , J , Landry , N , Lapointe , S , Lorin , A , Mahmood , A , Moulton , L H , Pahmer , E , Parent , J , Séguin , A , Tran , L , Breuer , T , Ceregido , M-A , Koutsoukos , M , Roman , F , Namba , J , D'Aoust , M-A , Trepanier , S , Kimura , Y , Ward , B J & CoVLP Study Team 2022 , ' Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine ' , The New England Journal of Medicine , vol. 386 , 2201300 , pp. 2084-2096 . https://doi.org/10.1056/NEJMoa2201300 | en |
dc.identifier.issn | 0028-4793 | |
dc.identifier.other | ORCID: /0000-0002-1397-4272/work/112886384 | |
dc.identifier.uri | http://aura-test.abdn.ac.uk/handle/2164/19465 | |
dc.description | Supported by Medicago with financial assistance from the Canadian Innovation, Science and Economic Development Strategic Innovation Fund. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org. A data sharing statement provided by the authors is available with the full text of this article at NEJM.org. We thank all the trial participants; the staff members at each site for their high degree of professionalism in the conduct of the trial; all the employees and contractors at Medicago and GSK for their support; and all the contributors to the GISAID initiative for generating the genetic sequences and metadata on which Figure S1 is based. | en |
dc.format.extent | 13 | |
dc.format.extent | 1099704 | |
dc.language.iso | eng | |
dc.relation.ispartof | The New England Journal of Medicine | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | R Medicine | en |
dc.subject | Supplementary Information | en |
dc.subject.lcc | R | en |
dc.title | Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1056/NEJMoa2201300 | |
dc.date.embargoedUntil | 2022-11-04 |